A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in Adults
Clinical trial NCT03795441 · COMPLETED
Trial details
- NCT number
- NCT03795441
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-07-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.